Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC
Cole Friedes, Michelle Iocolano, Sang Ho Lee, et al.
Radiotherapy and Oncology (2023) Vol. 190, pp. 110030-110030
Closed Access | Times Cited: 16

Showing 16 citing articles:

Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation
Nikhil Yegya‐Raman, Sang Ho Lee, Cole Friedes, et al.
Radiotherapy and Oncology (2023) Vol. 190, pp. 110005-110005
Closed Access | Times Cited: 16
Integrating knowledge-based planning and noncoplanar oblique VMAT arcs: A study of dose to the heart and immune cells in thoracic radiotherapy
Brennan Diedrich, Justin Roper, Benjamin Hopkins, et al.
Technical Innovations & Patient Support in Radiation Oncology (2025) Vol. 33, pp. 100301-100301
Closed Access
Characterization and dosimetric predictors for absolute lymphocyte count changes during neoadjuvant chemoradiotherapy with or without pembrolizumab for esophageal squamous cell carcinoma: an analysis of a prospective cohort
Wei‐Xiang Qi, Shuyan Li, Shujun Zhang, et al.
Radiation Oncology (2025) Vol. 20, Iss. 1
Open Access
Impact of radiation dose to immune cells on survival in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a retrospective analysis
Junfeng Zhao, Kang Wang, Ying Li, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation
Miguel Garrett Fernandes, Johan Bussink, Robin Wijsman, et al.
Radiotherapy and Oncology (2025) Vol. 206, pp. 110821-110821
Open Access
Enhancement of Prognostic Outcomes in Stage III Non-Small Cell Lung Cancer: A Retrospective Study on Neoadjuvant Immuno-Chemotherapy Followed by Definitive Chemo-Radiotherapy
Wenxin Ding, Yechen Ma, Hao Hu, et al.
Translational Oncology (2025) Vol. 56, pp. 102394-102394
Closed Access
Impact of estimated dose of radiation to immune cells (EDRIC) in locally advanced Non-Small-Cell lung Cancer: A secondary analysis of the multicenter randomized PET-Plan trial
Cas Stefaan Dejonckheere Nour, Younéss Nour, Jörg Sahlmann, et al.
Radiotherapy and Oncology (2025), pp. 110907-110907
Open Access
Kaplan lecture 2023: lymphopenia in particle therapy
Marco Durante
International Journal of Radiation Biology (2024) Vol. 100, Iss. 5, pp. 669-677
Open Access | Times Cited: 3
Determinants of radiation dose to immune cells during breast radiotherapy
Pierre Loap, Jérémi Vũ Bezin, Ludovic De Marzi, et al.
Strahlentherapie und Onkologie (2024)
Closed Access | Times Cited: 2
Proton therapy reduces the effective dose to immune cells in mediastinal Hodgkin lymphoma patients
Pierre Loap, Ludovic De Marzi, Justine Decroocq, et al.
International Journal of Particle Therapy (2024) Vol. 13, pp. 100110-100110
Open Access | Times Cited: 1
Irradiated Bone Marrow Volume is Associated with Hematologic Toxicity in Patients with Multiple Myeloma
Samuel C. Zhang, Sungjin Kim, J. Steers, et al.
International Journal of Radiation Oncology*Biology*Physics (2024)
Closed Access | Times Cited: 1
FLIP: a novel method for patient-specific dose quantification in circulating blood in large vessels during proton or photon external beam radiotherapy treatments
Marina García-Cardosa, R. Meiriño, Felipe A. Calvo, et al.
Physics in Medicine and Biology (2024) Vol. 69, Iss. 22, pp. 225017-225017
Closed Access | Times Cited: 1
Acute hospitalizations after proton therapy versus intensity‐modulated radiotherapy for locally advanced non–small cell lung cancer in the durvalumab era
Michelle Iocolano, Nikhil Yegya‐Raman, Cole Friedes, et al.
Cancer (2024) Vol. 130, Iss. 11, pp. 2031-2041
Closed Access
Proton therapy reduces the effective dose to immune cells in breast cancer patients
Pierre Loap, Jeremi Vu‐Bezin, Ludovic De Marzi, et al.
Strahlentherapie und Onkologie (2024) Vol. 200, Iss. 12, pp. 1074-1079
Closed Access
Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer
Arnaud Colomb, Benoît Allignet, Mehdi Lamkhioued, et al.
Radiation Oncology (2024) Vol. 19, Iss. 1
Open Access
Association between Dose to Cardiac Structures and Overall Survival: a Multivariable Analysis in a Large, Multi-Institutional Database of Stage III NSCLC Patients with External Validation
Miguel Garrett Fernandes, J. Bussink, Robin Wijsman, et al.
(2024)
Closed Access
Updates in Management of Unresectable Stage III Non Small Cell Lung Cancer: A Radiation Oncology Perspective
Lakshmi Rekha Narra, Ritesh Kumar, Matthew P. Deek, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4233-4233
Open Access
Page 1

Scroll to top